Home - Medical Policies - Alabama
- Advanced Imaging
- Autism Spectrum Mandate
- Behavioral Health
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- HealthSmartRx Smart RxAssist Program
- Hemophilia Drugs
- Medical Policies
- Provider-Administered Drug Policies (Excluding Oncology)
- Provider-Administered Oncology Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
- Transgender Services
Provider-Administered Oncology Drug Policies - Blue Advantage
Blue Advantage provider-administered oncology drug policies are based on the most current medical research available at the time of the policy development. We list final and draft provider-administered oncology policies as well as supportive drug policies. The draft policies are available for physician comment for 45-days from the posting date found on the document. We encourage practicing physicians to provide input.
Policies are written to cover a given therapy for the majority of people. Each individual's unique clinical circumstances may be considered in light of current scientific literature. Provider-administered oncology drug policies are based on constantly changing medical science and Blue Cross reserves the right to review and update our policies as necessary.